<DOC>
	<DOCNO>NCT02495454</DOCNO>
	<brief_summary>GA101-miniCHOP regimen treatment elderly unfit patient diffuse large B-cell non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>GA101-miniCHOP Regimen Treatment Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Obinutuzumab</mesh_term>
	<criteria>1 . Histologically proven CD20 positive Diffuse Large Bcell Lymphoma Follicular grade IIIB lymphoma , accord WHO classification ( local pathologist ) 2 . Age ≥ 65 year 3 . No previous treatment 4 . CGA assessment perform start treatment 5 . UNFIT patient define follow : Age &gt; 80 year FIT profile , i.e . ADL =6 residual function IADL=8 residual function CIRS : comorbidity grade 34 &lt; 5 grade 2 Age &lt; 80 UNFIT profile , i.e ADL &gt; 5 residual function IADL &gt; 6 residual function CIRS : comorbidity grade 34 58 comorbidities grade 2 6 . Ann Arbor Stage I bulky , IIIV 7 . At least one bidimensionally measurable lesion define &gt; 1.5 cm large dimension CT scan 8 . ECOG performance status 0 , 1 , 2 9 . Adequate hematologic function ( unless cause bone marrow infiltrate ) , define follow : Hemoglobin ≥ 10 g/dL Absolute neutrophil count ≥ 1.5 x 109/L Platelet count ≥ 100 x 109/L 10 . LVEF &gt; 50 % 11 . Ability willingness comply study protocol procedure 12 . Life expectancy &gt; 6 month 13 . Accessibility patient treatment follow 14 . Written inform consent 1 . History severe allergic anaphylactic reaction humanize murine monoclonal antibody know sensitivity allergy murine product 2 . Contraindication individual component CHOP , include prior receipt anthracyclines 3 . History malignancy within 5 year prior study entry except adequately treat carcinoma situ cervix basal squamous cell skin cancer 4 . Stage I without bulky 5 . Patients transform lymphoma 6 . Prior therapy DLBCL , exception nodal biopsy local irradiation 7 . Previous exposure cytotoxic agent 8 . Suspect clinical evidence CNS involvement lymphoma 9 . HBsAg , HCV HIV positivity ; isolate HBcAb positivity accept concomitant treatment Lamivudine 10 . AST /ALT &gt; twice upper normal range ; bilirubin &gt; twice upper normal range ; serum creatinine &gt; 2.5 mg /dl ( unless abnormality relate lymphoma ) 11 . Evidence severe active acute chronic infection 12 . Concurrent comorbid medical condition might exclude administration full dose chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>